Ann: US patent issued for DEP cabazitaxel nanoparticle, page-2

If this is what the secret squirrel stuff some were going on about earlier in the week, it is a bit of a fizzer .... good to see the patent granted but realistically it is not like it wasn't expected ? I mean who else were they going to award the patent to for DEP® cabazitaxel ?

It's not like Sanofi could dispute it as they don't own the DEP technology and let's face it, Starpharma didn't even nominate the announcement as price sensitive for the reasons I have outlined above

I guess we will see if Sanofi are interested enough in it to sign a deal whenever the trials finish next year (or the year after knowing SPL) ... we all know how DEP® Remdesivir went - JF is still waiting for Gilead to return her call IMO ?